Chris Cardon

Chris Cardon is a seasoned entrepreneur with extensive experience in the pharmaceutical and biotechnology sectors. As the founder of Ziphius Vaccines since July 2019, Chris Cardon focuses on developing next-generation vaccines utilizing self-amplifying RNA technology. Previously, Chris Cardon served on the Board of Directors at Animalcare Group Plc from July 2017 to July 2021 and founded Ecuphar, which was later renamed Animalcare Group, achieving a ranking of 25th among global veterinary pharmaceutical companies. Chris Cardon also founded Mooss Pharma, contributing to research, development, and sales of non-prescription human pharmaceutical products in the Benelux and French markets from 1996 to 2001. Educational qualifications include studies at Vlerick Business School and Ghent University.